All In Biotech

Drug Trial Radar · NCT00977080

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH With Paricalcitol-centered Therapy vs. Cinacalcet Therapy With Low-dose Vitamin D in Hemodialysis Patients With Secondary Hyperparathyroidism

Last checked: Nov 19, 2026Latest source record: Jun 20, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 272 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

272

Actual

Start

Nov 2009

Primary completion

May 2011

Study completion May 2011

Sponsor

Lead sponsor
AbbottIndustry
Sponsor type
Industry
First posted
Sep 15, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluates the effectiveness of on-label Paricalcitol versus Cinacalcet with Low-Dose Vitamin D.

Conditions

  • Chronic Kidney Disease
  • Secondary Hyperparathyroidism
  • Hemodialysis

Interventions

  • ParicalcitolDrug

    Paricalcitol dosed per label by region (participants were to receive cinacalcet if they developed hypercalcemia)

  • CinacalcetDrug

    On-label oral cinacalcet by region with low dose vitamin D receptor activator (VDRA) (either doxercalciferol at US sites or alfacalcidol at non-US sites)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Number of Participants Who Achieve a Mean Intact Parathyroid Hormone (iPTH) Value Between 150 to 300 pg/mL During the Evaluation Period (Weeks 21 to 28).Time frame: Weeks 21 to 28

Locations

83 sites in 12 countries. Site status is shown where the registry gives one.

  • Site Reference ID/Investigator# 22781

    Tempe, Arizona

  • Site Reference ID/Investigator# 24342

    Chula Vista, California

  • Site Reference ID/Investigator# 21142

    Los Angeles, California

  • Site Reference ID/Investigator# 22762

    Los Angeles, California

  • Site Reference ID/Investigator# 22758

    Riverside, California

  • Site Reference ID/Investigator# 21442

    San Diego, California

  • Site Reference ID/Investigator# 23688

    Arvada, Colorado

  • Site Reference ID/Investigator# 21370

    Coral Springs, Florida

  • Site Reference ID/Investigator# 25902

    Hudson, Florida

  • Site Reference ID/Investigator# 21146

    Lauderdale Lakes, Florida

  • Site Reference ID/Investigator# 26743

    Lauderdale Lakes, Florida

  • Site Reference ID/Investigator# 22788

    Miami, Florida

  • Site Reference ID/Investigator# 22722

    Orlando, Florida

  • Site Reference ID/Investigator# 23147

    Tampa, Florida

  • Site Reference ID/Investigator# 22778

    Meridian, Idaho

  • Site Reference ID/Investigator# 21369

    Detroit, Michigan

  • Site Reference ID/Investigator# 22786

    Detroit, Michigan

  • Site Reference ID/Investigator# 21144

    St Louis, Missouri

  • Site Reference ID/Investigator# 21443

    St Louis, Missouri

  • Site Reference ID/Investigator# 21145

    Omaha, Nebraska

  • Site Reference ID/Investigator# 22505

    Flushing, New York

  • Site Reference ID/Investigator# 22759

    Toledo, Ohio

  • Site Reference ID/Investigator# 22796

    Lancaster, Pennsylvania

  • Site Reference ID/Investigator# 22770

    Philadelphia, Pennsylvania

  • Site Reference ID/Investigator# 22772

    Aiken, South Carolina

  • Site Reference ID/Investigator# 21147

    Orangeburg, South Carolina

  • Site Reference ID/Investigator# 22982

    Houston, Texas

  • Site Reference ID/Investigator# 21143

    Houston, Texas

  • Site Reference ID/Investigator# 22506

    San Antonio, Texas

  • Site Reference ID/Investigator# 22776

    Bluefield, West Virginia

  • Site Reference ID/Investigator# 22311

    Brno, Czechia

  • Site Reference ID/Investigator# 22310

    Jilemnice, Czechia

  • Site Reference ID/Investigator# 21624

    Ústí nad Labem, Czechia

  • Site Reference ID/Investigator# 22363

    Aalborg, Denmark

  • Site Reference ID/Investigator# 23105

    Copenhagen, Denmark

  • Site Reference ID/Investigator# 23909

    Fredericia, Denmark

  • Site Reference ID/Investigator# 22462

    Holstebro, Denmark

  • Site Reference ID/Investigator# 21748

    Coburg, Germany

  • Site Reference ID/Investigator# 33268

    Darmstadt, Germany

  • Site Reference ID/Investigator# 35903

    Düsseldorf, Germany

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.